Free Trial

Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Shockwave Medical Right Now?

Before you consider Shockwave Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shockwave Medical wasn't on the list.

While Shockwave Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Kate Stalter
About The Author

Kate Stalter

Contributing Author

Retirement, Asset Allocation, and Tax Strategies

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRankâ„¢Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Shockwave Medical (SWAV)N/A$334.75flatN/A78.21N/AN/A
GE HealthCare Technologies (GEHC)
4.0685 of 5 stars
$75.96-0.4%0.18%15.99Moderate Buy$88.55
Intuitive Surgical (ISRG)
4.7015 of 5 stars
$518.620.5%N/A76.04Moderate Buy$592.86
Align Technology (ALGN)
4.804 of 5 stars
$190.77-0.8%N/A34.75Moderate Buy$242.92
Zimmer Biomet (ZBH)
4.9521 of 5 stars
$93.18-1.8%1.03%20.62Hold$111.39
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines